Fast-tracking cancer biomarkers from promise to practise (December, 2025)

BRECISE accelerates the transition of biomarkers from the laboratory into everyday clinical practice. The project develops tools for more precise treatment of prostate and bladder cancer, connects data, artificial intelligence and regulation, and creates a framework that can support patients, clinicians and healthcare systems across Europe in advancing personalised medicine and care.

Project Plenary Meeting, Madrid (March 2025.)

The BRECISE project is set to hold its first face-to-face kick-off meeting in Madrid on March 20–21, 2025. This event will bring together project partners to advance key objectives and foster collaboration in biomarker research and personalised medicine.

BRECISE Overview

The project aims to accelerate the clinical validation and implementatioon of Next-Generation Sequencing….

Future Stakeholder Engagement Forum (Q3 2025) (TBA)

BRECISE Platform

What is BRECISE and Why is Needed?

Kick-Off Meeting (February 2025)